Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-Müllerian hormone percentile

References

• Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. 2016. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. New England Journal of Medicine 375:523–533.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Baker VL. 2013. Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 304:69–72.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, et al. 2010. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism 95:4399–4405. Epub 2010 Jul 7.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. 2014. The physiology and clinical utility of anti-Mullerian hormone in women. Human Reproduction Update 20:370–385.
   PubMed Web of Science ®Google Scholar
• Doi SAR, Towers PA, Scott CJ, Al-Shoumer KAS. 2005. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis? European Journal of Obstetrics, Gynecology, and Reproductive Biology 118:4–16.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. 1999. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140:5789–5796.
   PubMed Web of Science ®Google Scholar
• Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. 2012. Consensus on Women's Health Aspects of Polycystic Ovary Syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97:28–38.e25.
   PubMed Web of Science ®Google Scholar
• Fong SL, Laven JSE, Duhamel A, Dewailly D. 2017. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Mullerian hormone using cluster analysis. Human Reproduction 32:1723–1731.
   PubMed Web of Science ®Google Scholar
• Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D, et al. 2017. Use of the serum anti-Mullerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome. Human Reproduction 32:1716–1722.
   PubMed Web of Science ®Google Scholar
• Franks S, McCarthy MI, Hardy K. 2006. Development of polycystic ovary syndrome: involvement of genetic and environmental factors . International Journal of Andrology 29:278–285.
   PubMedGoogle Scholar
• Hsu JY, James KE, Bormann CL, Donahoe PK, Pépin D, Sabatini ME, et al. 2018. Müllerian-inhibiting substance/anti-Müllerian hormone as a predictor of preterm birth in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 103:4187–4196.
   PubMed Web of Science ®Google Scholar
• Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F, et al. 2016. Anti-Müllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reproductive Medicine and Biology 15:127–136.
   PubMedGoogle Scholar
• Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. 2017. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Human Reproduction Update 23:139–155.
   PubMed Web of Science ®Google Scholar
• Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O, et al. 2011. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 343:d6309–d6309.
   PubMed Web of Science ®Google Scholar
• Roque M, Lattes K, Serra S, Solà I, Geber S, Carreras R, et al. 2013. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertility and Sterility 99:156–162.
   PubMed Web of Science ®Google Scholar
• Sha T, Yin X, Cheng W, Massey IY. 2018. Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis. Fertility and Sterility 109:330–342.e9.
   PubMed Web of Science ®Google Scholar
• Shebl O, Ebner T, Sir A, Schreier-Lechner E, Mayer RB, Tews G, Sommergruber M. 2011. Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort. Fertil Steril 95:832–834.
   PubMed Web of Science ®Google Scholar
• Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, et al. 2019. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Gynecological Endocrinology 35:595–600.
   PubMed Web of Science ®Google Scholar
• Stegmann BJ, Santillan M, Leader B, Smith E, Santillan D. 2015. Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth. Fertility and Sterility 104:347–355.e3.
   PubMed Web of Science ®Google Scholar
• Tata B, Mimouni NEH, Barbotin A-L, Malone SA, Loyens A, Pigny P, et al. 2018. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nature Medicine 24:834–846.
   PubMed Web of Science ®Google Scholar
• Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, et al. 2019. Anti-Müllerian hormone in PCOS: a review informing international guidelines. Trends in Endocrinology and Metabolism 30:467–478.
   PubMed Web of Science ®Google Scholar
• Valdimarsdottir R, Valgeirsdottir H, Wikström A-K, Kallak TK, Elenis E, Axelsson O, et al. 2019. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels. Reproductive Biomedicine Online 39:141–148.
   PubMed Web of Science ®Google Scholar
• Wachs DS, Coffler MS, Malcom PJ, Chang RJ. 2007. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. The Journal of Clinical Endocrinology and Metabolism 92:1871–1874.
   PubMed Web of Science ®Google Scholar
• Zong L, Liu P, Zhou L, Wei D, Ding L, Qin Y, et al. 2020. Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer. Reproductive Biology and Endocrinology 18:36.
   PubMed Web of Science ®Google Scholar